Microscopic probe takes internal images while measuring temperature

Researchers from the University of Adelaide in Australia have developed a microscopic probe capable of measuring temperatures while inside the body. Study findings are published in the April 15 edition of Optics Letters.

The tiny fiber-optic probe, which can take images and measure temperature within the body, was developed to assist treatment to prevent drug-induced overheating of the brain. While this is the first version of the probe, researchers hope to eventually use it to develop thermal treatment for cancers as well.

 

"With an outer diameter of only 130 microns, the probe is as thin as a single strand of human hair," said Jiawen Li, a researcher with the Adelaide Medical School, ARC Centre of Excellence for Nanoscale Biophotonics (CNBP) and the Institute for Photonics and Advanced Sensing (IPAS). "This means it can be delivered deep inside the body in a minimally invasive way. It also allows us to see and record physiological data in real time that we weren't able to access before."

The microscopic imaging and sensing probe could improve the current understanding of how hyperthermia develops in the brain due to drug use. The probe also has the potential to optimize the thermal treatment of cancer by measuring temperature and sending images to clinicians. Future versions of the probe may include measurements such pH values, oxygen saturation and accumulation of fat in arteries.

"Using the probe's imaging function during experiments, our medical collaborators would be able to see deep inside the brain of a living organism and guide the placement of the probe to the right brain region,” said Li. “Then, they can use the probe's built-in thermometer to monitor any changes to the local temperature of that region.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.